REPH Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (22 kov. 2022 @ 06:00):

Stats
Šios dienos apimtis	137 536
Vidutinė apimtis	128 488
Rinkos kapitalizacija	177.42M
EPS	$-0.0000600 ( 2023-03-30 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-8.04
ATR14	$0.0920 (4.40%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-02	Lake Ryan David	Sell	1 419	Common Stock
2023-12-15	Lake Ryan David	Sell	5 690	Common Stock
2023-11-30	Lake Ryan David	Sell	1 197	Common Stock
2023-10-31	Lake Ryan David	Sell	1 198	Common Stock
2023-09-30	Lake Ryan David	Sell	1 198	Common Stock

INSIDER POWER
94.69
Last 95 transactions
Buy: 16 300 004 \| Sell: 826 395

Tūris Koreliacija

Ilgas: -0.07 (neutral)

Trumpas: 0.64 (weak)

Signal:(67.783) Neutral

Recro Pharma Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
CNDT	0.875
EGBN	0.874
ANNX	0.87
FEYE	0.863
CYXT	0.863
FNWB	0.861
DCOMP	0.858
FFWM	0.852
ATHA	0.846
BWBBP	0.843

10 Labiausiai neigiamai susiję koreliacijos
NRDS	-0.898
SGTX	-0.876
NVTS	-0.859
PESI	-0.851
MORF	-0.848
WVVI	-0.844
BTBD	-0.839
FTIV	-0.837
INOD	-0.836
AMRB	-0.835

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Recro Pharma Inc Koreliacija - Valiuta/Žaliavos

0.43
( neutral )

0.42
( neutral )

0.00
( neutral )

0.50
( neutral )

0.16
( neutral )

-0.50
( neutral )

Recro Pharma Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$94.64M
Bruto pelnas:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2023
Pajamos:	$94.64M
Bruto pelnas:	$18.14M (19.17 %)
EPS:	$-0.000100

FY	2022
Pajamos:	$90.21M
Bruto pelnas:	$23.14M (25.65 %)
EPS:	$-0.340

FY	2021
Pajamos:	$75.36M
Bruto pelnas:	$19.82M (26.30 %)
EPS:	$-0.221

Financial Reports:

No articles found.

Recro Pharma Inc

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.